Association of Tramadol-Induced Ovarian Damage and Reproductive Dysfunction with Adenosine Triphosphate and the
Neset Gumusburun1, Ilhan Bahri Delibasi1, Seval Bulut2
1Department of Gynecology and Obstetrics, Medical Park Tokat Hospital, Tokat 60030, Türkiye.
Abstract:
Background: Tramadol, a weak opioid analgesic agent, is known to induce ovarian damage. Previous studies have held oxidative stress responsible for the adverse effects of tramadol on female reproduction. This study examined the protective effects of ATP against tramadol-induced ovarian damage and reproductive dysfunction in rats. Methods: Rats were divided into four groups (n = 12); healthy (HG), only ATP (ATPG), only tramadol (TMDG), and ATP + tramadol (ATMG). ATP was injected intraperitoneally at 25 mg/kg. Tramadol at 50 mg/kg was initiated one hour after ATP. The treatment was administered once a day for 14 days. Six rats from each group were euthanized. For two months, the remaining rats were paired with male rats. Rats that failed to give birth during this period were considered infertile. A maternity period was calculated for the rats that were delivered. Results: Tramadol caused an increase in malondialdehyde and interleukin-6, and decreased total glutathione, superoxide dismutase, and catalase levels in the ovarian tissue. Furthermore, tramadol disrupted the histological structure of the ovaries, and immunohistochemical staining revealed severe immunopositivity. Tramadol again caused infertility and delayed pregnancy in fertile women. By suppressing biochemical changes, ATP significantly reduced tramadol-induced ovarian damage. Both histopathologically and immunohistochemically, ATP treatment regressed ovarian damage. Additionally, ATP significantly reduced tramadol-induced infertility and maternal delay. Conclusions: The results indicate that tramadol-induced oxidative and inflammatory ovarian injury, infertility, and caspase 3 were suppressed by ATP, as demonstrated by our experimental findings.
Insights
Adenosine triphosphate (ATP) protects against tramadol-induced ovarian damage and infertility in rats. This study demonstrates ATP
Area of Science:
- Reproductive Toxicology
- Biochemistry
Background:
- Tramadol, a weak opioid analgesic, is known to cause ovarian damage.
- Oxidative stress is implicated in tramadol's adverse effects on female reproduction.
Purpose of the Study:
- To investigate the protective effects of adenosine triphosphate (ATP) against tramadol-induced ovarian damage and reproductive dysfunction in a rat model.
Main Methods:
- Rats were divided into four groups: healthy, ATP only, tramadol only, and ATP + tramadol.
- Treatments were administered daily for 14 days.
- Ovarian tissue was analyzed for biochemical markers, histology, and immunohistochemistry. Reproductive outcomes including fertility and pregnancy were assessed.
Main Results:
- Tramadol increased oxidative stress markers (malondialdehyde) and inflammation (interleukin-6) while decreasing antioxidant levels (glutathione, superoxide dismutase, catalase).
- Tramadol disrupted ovarian histology and induced infertility and delayed pregnancy.
- ATP treatment significantly ameliorated tramadol-induced biochemical, histological, and reproductive impairments.
Conclusions:
- ATP effectively suppressed tramadol-induced oxidative and inflammatory ovarian injury.
- ATP mitigated tramadol's negative impact on fertility and pregnancy outcomes in rats.
- ATP demonstrated protective effects against tramadol-induced reproductive toxicity.
Related Concept Videos
Hydrolysis of ATP
If one phosphate group is removed, a molecule of ADP—adenosine diphosphate—remains, along with inorganic phosphate. ADP can be further hydrolyzed to AMP—adenosine...
Oogenesis


